ROIV
Roivant Sciences Ltd
39.80$
-0.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| – | +78.5% | +8.6% | -3.9% | -7.6% | +202.2% | -24.7% | +5.4% | |
| – | +87.2% | -1.5% | -1.9% | -16.2% | +274.3% | -25.7% | +3.3% | |
| – | +157.3% | -2.4% | -3.4% | -18.6% | +289.8% | -58.5% | -47.6% | |
| – | +157.3% | -2.4% | -3.4% | -18.4% | +288.9% | -25.3% | -12.1% | |
| – | +39.3% | -9.5% | -51.3% | +459.2% | +120.0% | – | – | |
| – | – | +6,386,899,900.0% | -125.8% | – | +1,176.7% | – | – | |
| – | +565.4% | +4.2% | -66.4% | +50.9% | – | – | – | |
| – | – | – | – | – | -4.9% | – | – | |
| – | -18.2% | +43.3% | -0.8% | +49.3% | -1.0% | -67.7% | +74.4% | |
| – | -56.4% | +137.7% | -15.8% | +47.8% | -2.1% | -44.0% | +88.2% | |
| – | -63.0% | +57.1% | -7.4% | +359.8% | -58.2% | -55.0% | +13.3% | |
| – | +65.3% | +99.4% | +68.3% | +9.4% | +40.7% | -55.5% | -24.0% | |
| – | – | – | +23.3% | +78.8% | +14.7% | – | – | |
| – | +116.8% | -6.6% | -12.7% | -30.1% | +415.5% | -21.5% | -3.4% | |
| – | – | – | – | – | – | -79.9% | -532.4% | |
| – | +218.0% | +0.0% | -2.2% | +6.4% | +16.6% | -12.7% | -4.3% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.